Skip to content
  • Home
  • Our research
  • Market
  • Press release
  • Reports
  • Plans
  • Partnering
  • About us
Menu
  • Home
  • Our research
  • Market
  • Press release
  • Reports
  • Plans
  • Partnering
  • About us

Delårsrapport kvartal 3, 2021

Contact us

Kristian Lykke Fick

Send e-mail
Twitter Linkedin Facebook Youtube
As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising novel and proprietary dermatological drug candidate FOL005. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.
© All Rights Reserved